MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
National Research Corporation P/S Ratio 2011-2026 | NRC
Annual P/S Ratio National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.79 | 7.51 | 7.15 | 8.51 | 13.4 | 8.88 | 7.64 | 3.81 | 3.57 | 3.4 | 4.04 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 | 3.4 | 6.79 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
8.09 | $ 19.04 | 0.11 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 20.25 | -3.5 % | $ 217 M |  China |
 |
Co-Diagnostics
CODX
|
5.13 | $ 5.35 | 5.87 % | $ 157 M | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 38.31 | -1.52 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
6.37 | $ 230.53 | 0.7 % | $ 169 B | USA |
 |
DexCom
DXCM
|
13.5 | $ 66.36 | -0.02 % | $ 25.6 B | USA |
 |
BioNano Genomics
BNGO
|
0.115 | $ 1.56 | 1.96 % | $ 1.98 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
2.13 | $ 11.2 | -1.58 % | $ 318 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.8 | 0.24 % | $ 18.9 B | USA |
 |
IQVIA Holdings
IQV
|
2.31 | $ 225.76 | 0.16 % | $ 40.9 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 25.77 | -1.9 % | $ 779 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
CareDx, Inc
CDNA
|
1.86 | $ 19.08 | 1.27 % | $ 1.03 B | USA |
 |
Anixa Biosciences
ANIX
|
0.337 | $ 3.11 | -0.32 % | $ 99.2 K | USA |
 |
Myriad Genetics
MYGN
|
1.16 | $ 6.23 | 1.22 % | $ 564 M | USA |
 |
Guardant Health
GH
|
7.91 | $ 101.54 | -0.59 % | $ 12.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.21 | -7.06 % | $ 2.26 M | USA |
 |
NeoGenomics
NEO
|
2.31 | $ 11.7 | -0.51 % | $ 1.48 B | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
OPKO Health
OPK
|
6.61 | $ 1.32 | 4.37 % | $ 916 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 27.16 | 0.3 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
0.572 | $ 23.35 | 1.61 % | $ 30.3 M | USA |
 |
Personalis
PSNL
|
3 | $ 7.95 | -0.13 % | $ 471 M | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | Israel |
 |
Illumina
ILMN
|
3.75 | $ 132.66 | 1.14 % | $ 21.1 B | USA |
 |
Charles River Laboratories International
CRL
|
2.11 | $ 200.04 | 0.28 % | $ 10.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 172.92 | -0.35 % | $ 19.2 B | USA |
|
Biodesix
BDSX
|
1.29 | $ 6.72 | -1.25 % | $ 871 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 251.95 | 0.43 % | $ 21.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 188.4 | 3.39 % | $ 15.5 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
9.66 | $ 664.7 | -1.75 % | $ 54.8 B | USA |
 |
Lantheus Holdings
LNTH
|
4.21 | $ 67.47 | 1.38 % | $ 4.67 B | USA |
 |
Mettler-Toledo International
MTD
|
7.72 | $ 1 406.1 | 0.85 % | $ 29.8 B |  Schweiz |
 |
Agilent Technologies
A
|
6.64 | $ 137.01 | 0.69 % | $ 41.7 B | USA |